Buscar
01/11/2024
SEOM clinical guidelines for cancer anorexia-cachexia syndrome (2023).
Soria Rivas A, Escobar Álvarez Y, Blasco Cordellat A, Majem Tarruella M, Molina Mata K, Motilla de la Cámara M, Del Mar Muñoz Sánchez M, Zafra Poves M, Beato Zambrano C, Cabezón Gutierrez L. SEOM clinical guidelines for cancer anorexia-cachexia syndrome (2023).. Clinical & Translational Oncology. 2024; 26(11)DOI:10.1007/s12094-024-03502-8. PMID:38822976. IF:(Q/D).
30/10/2024
Dupilumab treatment in paediatric atopic dermatitis (2-18 years): Spanish multicentre retrospective real-world study
Iznardo, H, Roé, E, Vicente, A, Prat, C, Casals, M, Martín-Santiago, A, Esteve, A, Viñas, M, Munera-Campos, M, Corella, F, Mollet, J, Figueras-Nart, I, Vila, A, Soria, X, Azón-Masoliver, A, Marqués-Martín, L, Nadal-Lladó, C, Bel, S, Pujol-Montcusí, J, Bertolín-Colilla, M, Curto-Barredo, L, Melé-Ninot, G, Evole, M, Berbegal, L, Puig, L, Baselga, E. Dupilumab treatment in paediatric atopic dermatitis (2-18 years): Spanish multicentre retrospective real-world study. CLINICAL AND EXPERIMENTAL DERMATOLOGY. 2024; 50(1)DOI:10.1093/ced/llae300. PMID:39093288. IF:2.800(Q2/4D).
29/10/2024
BRIVA-ONE study: 12-month outcomes of brivaracetam monotherapy in clinical practice
Villanueva, V, Villar, EG, Fernandez-Cabrera, A, Zurita, J, Lopez-Gonzalez, FJ, Rodríguez-Osorio, X, Parejo-Carbonell, B, Estevez, JC, Mercedes-Alvarez, B, Ojeda, J, Rubio-Roy, M, Garcia-Escrivá, A, Gómez-Ibáñez, A, Martinez-Poles, J, Martinez-Agredano, P, Calle, R, Sierra-Marcos, A, Gonzalez, AM, Herrera, JD, Rodriguez-Uranga, J, Cabezas, B, Martinez, E, Renau, J, de Toledo, M, Hampel, KG, Alarcón, C, Barceló, MI, Monterde, A, Lara, LB, Sansa, G, Serratosa, JM. BRIVA-ONE study: 12-month outcomes of brivaracetam monotherapy in clinical practice. Epilepsia Open. 2024; 9(6)DOI:10.1002/epi4.13078. PMID:39470722. IF:2.900(Q2/4D).
29/10/2024
Incidence, Predictors, and Clinical Impact of Early Safety After Transcatheter Aortic Valve Replacement According to VARC-3 Criteria
Avvedimento, M, Gonzálvez-García, A, Cepas-Guillen, PL, Ternacle, J, Urena, M, Alperi, A, Fernández, GV, Franco, LN, Vilalta, V, Esposito, G, Campelo-Parada, F, Indolfi, C, Del Trigo, M, Munoz-Garcia, A, Melon, NMM, Asmarats, L, Regueiro, A, del Val, D, Auffret, V, Beaumont, E, Rodes-Cabau, J. Incidence, Predictors, and Clinical Impact of Early Safety After Transcatheter Aortic Valve Replacement According to VARC-3 Criteria. JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2024; 84(18)DOI:. PMID:. IF:22.300(Q1/1D).
29/10/2024
Validation of the Valve Academic Research Consortium High Bleeding Risk Definition in Patients Undergoing Transcatheter Aortic Valve Replacement
Avvedimento, M, Cepas, P, Ternacle, J, Urena, M, Alperi, A, Fernandez, GV, Franco, LN, Vilalta, V, Esposito, G, Campelo-Parada, F, Indolfi, C, Del Trigo, M, Munoz-Garcia, A, Melon, NMM, Asmarats, L, Regueiro, A, del Val, D, Auffret, V, Cote, M, Mehran, R, Capodanno, D, Garot, P, Rodes-Cabau, J. Validation of the Valve Academic Research Consortium High Bleeding Risk Definition in Patients Undergoing Transcatheter Aortic Valve Replacement. JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2024; 84(18)DOI:. PMID:. IF:22.300(Q1/1D).
29/10/2024
Development and validation of the post-CAR prognostic index for large B-cell lymphoma patients after CAR-T progression in third or later line treatment.
Iacoboni G, Navarro V, Sesques P, Rejeski K, Bastos-Oreiro M, Serpenti F, Martin Lopez AA, Iraola-Truchuelo J, Delgado J, Perez A, Guerreiro M, Caballero AC, Martinez-Cibrian N, Luzardo Henriquez H, Sanchez Pina JM, Sancho JM, Ghesquieres H, Mussetti A, Lopez Corral L, Hernani R, Reguera JL, Sureda A, Bosch F, Martin Garcia-Sancho A, Kwon M, Subklewe M, Kuhnl A, Bachy E, Barba P, Villacampa G, Abrisqueta P. Development and validation of the post-CAR prognostic index for large B-cell lymphoma patients after CAR-T progression in third or later line treatment.. Journal of Hematology & Oncology. 2024; 17(1)DOI:10.1186/s13045-024-01608-8. PMID:39468591. IF:(Q/D).
28/10/2024
Hereditary transthyretin amyloidosis caused by Val142Ile variant in Spain: phenotypic characteristics, geographic distribution and population frequency
Seminario, FD, Aventin, BP, Eiros, R, Freire, JL, Sevilla, T, Carbayo, A, Llongueras, P, Garcia-Alvarez, A, Ripoll-Vera, T, Macias, R, Vilches, S, Ruiz-Bustillo, S, Achaga, XA, Ordas, JG, Gonzalez-Costello, J. Hereditary transthyretin amyloidosis caused by Val142Ile variant in Spain: phenotypic characteristics, geographic distribution and population frequency. EUROPEAN HEART JOURNAL. 2024; 45DOI:10.1093/eurheartj/ehae666.2073. PMID:. IF:35.600(Q1/1D).
28/10/2024
Effects of exercise referral schemes enhanced with behavioural self-management strategies on functional capacity and self-reported disability in community-dwelling older adults. Secondary results from the SITLESS multi-country, three-armed randomized controlled trial
Olsen, PO, Tully, MA, Cruz, BD, Giné-Garriga, M, Coll-Planas, L, Roqué, M, Rothenbacher, D, Dallmeier, D, Sansano-Nadal, O, Blackburn, NE, Wilson, JJ, Skjodt, M, Caserotti, P. Effects of exercise referral schemes enhanced with behavioural self-management strategies on functional capacity and self-reported disability in community-dwelling older adults. Secondary results from the SITLESS multi-country, three-armed randomized controlled trial. AGE AND AGEING. 2024; 53(10)DOI:10.1093/ageing/afae225. PMID:39468725. IF:7.100(Q1/1D).